Mitotic errors produce daughter cells with the wrong number of chromosomes, broken DNA, or both. In most cases, built-in surveillance systems catch the mistake and either fix it or kill the cell before it can do harm. When those safeguards fail, the consequences range from a single cell quietly entering permanent retirement to the kind of runaway genomic chaos that fuels tumor growth. The story of what happens when mitosis goes wrong is really a story about how many layers of defense stand between a copying error and a disease, and what it takes to breach them all.
The Checkpoint That Stops Everything
Cells do not just barrel through division hoping for the best. Before chromosomes are pulled apart, a surveillance system called the spindle assembly checkpoint scans every chromosome to confirm it is properly attached to the molecular cables (called microtubules) that will drag each copy to opposite ends of the cell. Even a single unattached chromosome is enough to trigger this checkpoint and halt the process. The strength of the stop signal scales with the number of loose chromosomes: more unattached chromosomes produce a stronger “wait” signal, giving the cell time to fix the problem before proceeding.1PubMed Central. Spindle assembly checkpoint activation and silencing at kinetochores
If a chromosome has attached to the cables but in the wrong orientation, a different repair system kicks in. A protein called Aurora B detects the incorrect attachment and destabilizes it, essentially unhooking the chromosome so it gets a fresh chance to attach correctly.2PubMed. Regulation of kinetochore-microtubule attachments by Aurora B kinase Correct attachments are left alone while faulty ones are actively dismantled.3PubMed Central. Correcting aberrant kinetochore microtubule attachments: an Aurora B-centric view Together, these two systems catch most mistakes before a cell ever finishes dividing. The trouble starts when they don’t.
Three Fates of a Stalled Cell
When the checkpoint keeps a cell paused for too long because errors cannot be resolved, the cell faces a three-way fork. It can eventually complete division anyway, it can die right there during mitosis, or it can undergo what researchers call “mitotic slippage,” where it drops back into a resting state without having divided at all.4PubMed Central. The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?
Mitotic slippage sounds harmless, but it leaves behind a cell with double the normal DNA content. In untransformed (healthy) cells, that doubled-up state triggers yet another safeguard. The protein p53, often called the cell’s “guardian,” recognizes something is off and prevents the tetraploid cell from dividing again. Many of these cells eventually enter senescence, a permanent state of growth arrest where the cell stays alive but stops proliferating for good.5PubMed Central. Tetraploid cells produced by absence of substrate adhesion during cytokinesis are limited in their proliferation and enter senescence after DNA replication This is the body’s way of quarantining a potentially dangerous cell. The problem arises when p53 itself is broken, which it is in the majority of advanced cancers.
Lagging Chromosomes and Why Most Get Rescued
Even in cells that pass the checkpoint and begin dividing, things can still go sideways. One common glitch is a “lagging chromosome,” a chromosome that falls behind as the two sets are pulled apart. In lab studies, about 9% of normal human cells displayed at least one lagging chromosome during division, and the rate jumped to 44% in cancer-prone cell lines. That sounds alarming, but there is a catch: most lagging chromosomes get corrected on the fly. Only about 6% of the lagging chromosomes in normal cells and 9% in cancer cell lines ended up trapped outside the main nucleus in tiny structures called micronuclei.6PubMed Central. An anaphase surveillance mechanism prevents micronuclei formation from frequent chromosome segregation errors An active surveillance mechanism during the final stage of division pushes most stragglers back into the correct nucleus before the cell seals shut.
This means chromosome segregation errors are far more frequent than their downstream consequences suggest. The cell has one more chance to save itself even after the main checkpoint has been passed, and it usually succeeds.
When a Chromosome Gets Trapped in a Micronucleus
The small fraction of lagging chromosomes that do end up in a micronucleus face a grim fate. Micronuclei have fragile membranes that tend to rupture, exposing the trapped DNA to enzymes in the surrounding cell fluid that were never supposed to touch it. A 2025 study identified a specific enzyme, N4BP2, that enters ruptured micronuclei and chops the exposed chromosome into fragments. This fragmentation can trigger chromothripsis, a catastrophic event where a chromosome is shattered and reassembled in a scrambled order, sometimes generating small circular DNA structures called extrachromosomal DNA. These rearrangements can activate cancer-driving genes and accelerate tumor growth.7PubMed Central. Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes
Chromothripsis was once thought to be a rare freak accident. It is now recognized as surprisingly common in many cancer types. What makes it especially dangerous is that a single event can introduce dozens of mutations simultaneously, potentially jumping over the slow, step-by-step accumulation of genetic damage that most models of cancer development assume.
Does the Immune System Notice?
When micronuclei rupture and spill DNA into the cell’s interior, that misplaced DNA looks, to the cell’s own sensors, a lot like an invading virus. A protein called cGAS can recognize this out-of-place DNA and trigger an inflammatory alarm through a pathway that normally defends against infections. A landmark 2017 study showed that cGAS rapidly accumulates inside ruptured micronuclei and that the resulting inflammatory response depends on cells having gone through division, consistent with a mitotic origin.8PubMed Central. cGAS surveillance of micronuclei links genome instability to innate immunity
This finding generated enormous excitement because it suggested that mitotic errors could recruit the immune system to attack damaged cells. But the picture has gotten murkier. More recent studies found that even though cGAS does localize to ruptured micronuclei, it does not always switch on. Two independent groups reported that in their experimental systems, micronuclei formed after certain types of DNA damage failed to activate the downstream signaling cascade: no production of the alarm molecule cGAMP, no activation of the pathway’s relay proteins, and no increase in immune-response genes.9Molecular Cell. Genotoxin-induced micronuclei fail to activate cGAS-STING10Life Science Alliance. Micronucleus is not a potent inducer of the cGAS/STING pathway
The disagreement likely comes down to context: how the micronucleus formed, what kind of cell it formed in, and what other signals are present. The immune connection is real in some settings but not the universal alarm system early reports implied. For cancer immunotherapy, this matters a great deal because treatments designed to exploit this pathway need to know when it actually fires and when it stays silent.
Aneuploidy and the Stress It Creates
When a mitotic error does produce a daughter cell with the wrong chromosome count, that cell faces immediate physiological problems beyond just having extra or missing genes. Extra chromosomes mean extra genes being read, which means extra proteins being built. Cells are finely tuned to handle a specific protein load, and the surplus overwhelms the quality-control machinery that folds proteins into the correct shapes. Research in yeast has shown that aneuploid cells live under constant protein-folding stress, which diverts energy and resources away from normal functions.11PubMed Central. Aneuploidy causes proteotoxic stress in yeast
This stress is one reason aneuploidy is usually harmful. In humans, most whole-chromosome gains or losses in a developing embryo are lethal. The few that are survivable, like the extra copy of chromosome 21 that causes Down syndrome, produce serious developmental consequences. The protein imbalance alone is enough to disrupt cellular processes across the body.
Chromosomal Instability and Cancer
While aneuploidy from a single error is usually a dead end for the cell, a sustained pattern of mitotic mistakes creates something far more dangerous. Chromosomal instability, or CIN, refers to an ongoing elevated rate of chromosome gain and loss across many cell divisions. It is a hallmark of most human cancers.12PubMed Central. Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution
CIN matters because it generates diversity within a tumor. Every round of flawed division shuffles the genetic deck, producing subpopulations of cells with slightly different chromosome combinations. Some of those combinations happen to make cells grow faster, resist chemotherapy, or evade the immune system. This is essentially evolution on fast-forward, playing out inside a single tumor over weeks and months. Clinically, CIN is associated with worse patient outcomes and greater drug resistance, likely because the tumor keeps evolving new ways to survive whatever treatment is thrown at it.13PubMed Central. Cancer chromosomal instability: therapeutic and diagnostic challenges
One contributor to CIN is having extra centrosomes, the structures that organize the cables pulling chromosomes apart. Cancer cells frequently accumulate extra centrosomes, which could theoretically split a cell three or four ways instead of two. In practice, most cancer cells with extra centrosomes cluster them into two functional groups before dividing, allowing a roughly normal two-way split. The clustering is imperfect, though, and produces low-level chromosome missegregation that feeds CIN without killing the cell outright.14PubMed Central. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes
Mitotic Errors in Early Embryos
The very first cell divisions after fertilization are surprisingly error-prone. In a study of over 1,200 human embryos at the cleavage stage, about 45% were mosaics, meaning their cells did not all carry the same chromosome count. The most common type of mosaicism was “chaotic,” with wildly different chromosome numbers from cell to cell, followed by gains of entire extra chromosome sets and errors from individual chromosomes failing to separate properly.15Reproductive BioMedicine Online. Chromosome mosaicism in cleavage-stage human embryos: evidence of a maternal age effect
Research in mice has confirmed that the earliest cleavage divisions are particularly prone to chromosome missegregation, suggesting a temporal window of vulnerability before the embryo’s own checkpoint machinery is fully up and running.16Human Molecular Genetics. Analysis of a malsegregating mouse Y chromosome: evidence that the earliest cleavage divisions of the mammalian embryo are non-disjunction-prone Many of these mosaic embryos either self-correct (by selectively eliminating aneuploid cells) or fail to implant. But the sheer frequency of early errors helps explain why human reproduction is so inefficient compared with other mammals: many pregnancies end before a woman even knows she is pregnant, in part because mitotic errors made the embryo nonviable.
When the Brain Is at Stake
The developing brain is an arena where even subtle mitotic errors can have outsized effects. Neural progenitor cells divide in carefully controlled orientations: some divisions produce two identical progenitors (expanding the pool), while others produce one progenitor and one neuron (building the brain). The angle of the division plane determines which type of daughter cells emerge. Research has shown that spindle orientation in the developing cortex helps determine whether a division produces new types of progenitor cells, including a population called outer radial glia that is thought to have been critical in the evolutionary expansion of the human brain.17PubMed Central. Spindle orientation in mammalian cerebral cortical development
Mutations that disrupt this process can cause microcephaly, a condition in which the brain is abnormally small. The logic is straightforward: if progenitor divisions are misdirected and produce neurons too early, the progenitor pool is depleted before the brain reaches its proper size. Several genes linked to primary microcephaly encode proteins that sit at the spindle poles or help orient the division plane, underscoring how sensitive brain development is to the mechanics of mitosis.
Mosaic Variegated Aneuploidy
A rare inherited condition called mosaic variegated aneuploidy, or MVA, offers a natural experiment in what happens when the spindle assembly checkpoint is genetically weakened from birth. People with MVA carry mutations in genes that encode checkpoint components or related proteins involved in centrosome function during division.18PubMed. Mosaic variegated aneuploidy in development, ageing and cancer As a result, their cells missegregate chromosomes at a much higher rate than normal, producing a patchwork of cells with different chromosome counts throughout the body.
The clinical consequences are severe: growth retardation, intellectual disability, and a dramatically increased risk of childhood cancers, particularly Wilms tumor and rhabdomyosarcoma. MVA demonstrates that the checkpoint is not just important for avoiding cancer in adults but is essential for normal development from the very start. It also illustrates that the link between mitotic errors and cancer is not merely a statistical association observed in tumors; it is a causal chain visible when the checkpoint is weakened in every cell of the body.
The Aging Connection
Mitotic fidelity does not stay constant over a lifetime. One of the clearest examples involves eggs. A woman’s eggs begin the division process before she is born and then pause, sometimes for decades, before completing it at ovulation. During that long pause, a protein complex called cohesin, which holds chromosome pairs together, gradually deteriorates. The progressive loss of cohesin has been strongly implicated in the rising rate of chromosome errors in eggs from older mothers.19PubMed. Causes and consequences of chromosomal cohesin loss: Novel insights for mechanisms of aging-related oocyte aneuploidy This is a major reason why conditions like Down syndrome become more common with advancing maternal age: the physical glue holding chromosomes together has had decades to wear out.
Beyond reproduction, age-related accumulation of aneuploid cells in various tissues has been proposed as a contributor to the general decline in tissue function with aging. Senescent cells produced by failed divisions can secrete inflammatory signals that damage neighboring healthy tissue, a process that has become a hot area of aging research.
Turning Mitotic Errors Into Cancer Therapy
If mitotic errors can cause cancer, can they also be weaponized against it? That is the logic behind some of the oldest and most widely used cancer drugs. Taxol and vinblastine work by disrupting the spindle cables, trapping cancer cells in a prolonged mitotic arrest that ultimately triggers cell death.20Cell Research. Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells The approach is blunt: any rapidly dividing cell is vulnerable, which is why these drugs cause side effects in fast-turnover tissues like the gut lining and bone marrow.
A newer and more counterintuitive strategy goes in the opposite direction. Instead of prolonging mitosis to induce death, it deliberately disables the checkpoint so that cells rush through division without pausing to fix errors. Inhibitors of the checkpoint kinase MPS1 force cells into mitosis regardless of whether chromosomes are properly attached, producing such severe aneuploidy that the daughter cells cannot survive.21PubMed. Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase22PubMed Central. Small Molecule Kinase Inhibitors Provide Insight into Mps1 Cell Cycle Function The bet is that cancer cells, which already have compromised checkpoints and unstable genomes, are more sensitive to losing their remaining safety net than healthy cells are. Early clinical candidates based on this idea have entered trials, though the therapeutic window is narrow.
When Mitotic Errors Help Instead of Harm
In fungi, the story takes an unexpected turn. Pathogenic fungi like Candida species routinely generate aneuploid cells when exposed to antifungal drugs. The drug stress itself induces mitotic defects that first produce cells with doubled chromosome sets, followed by missegregation events that scramble chromosome numbers. Some of those scrambled combinations happen to carry extra copies of genes that confer drug resistance, and natural selection quickly enriches for those cells in the population.23PubMed Central. Ploidy dynamics and evolvability in fungi
This is mitotic error as an adaptive strategy rather than a catastrophe. Because aneuploidy reshuffles gene dosage far more rapidly than point mutations do, it allows fungal populations to explore a vast landscape of possible genetic configurations in a short time. The downside for us is obvious: it makes fungal infections harder to treat, and it means that the very drugs meant to kill the pathogen can accelerate its evolution toward resistance. In a sense, the same process that drives human cancer, chromosomal instability generating selectable diversity, is being harnessed by fungal pathogens for survival.